Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia

被引：0
|
作者：
Aldoss, Ibrahim [1 ]
Tizro, Parastou [2 ]
Bedi, Davsheen [3 ]
Mangan, James K. [4 ,5 ]
Clark, Mary C. [1 ]
Spencer, David
Song, Joo Y. [2 ]
Cherian, Sindhu [6 ]
Pillai, Raju [2 ]
Kim, Young [2 ]
Mahajan, Nitin [7 ]
Gendzekhadze, Ketevan [8 ]
James, Mike [7 ]
Jacobs, Kenneth [7 ]
Davidson-Moncada, Jan [7 ]
Forman, Stephen J. [1 ]
Wang, Huan-You [3 ]
Afkhami, Michelle [2 ]
机构：
[1] City Of Hope, Gehr Family Ctr Leukemia Res, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA
[2] City Of Hope, Dept Pathol, Duarte, CA USA
[3] Univ Calif San Diego, Dept Pathol, La Jolla, CA USA
[4] Univ Calif San Diego, Moores Canc Ctr, Dept Med, Div Blood & Marrow Transplantat, La Jolla, CA USA
[5] Washington Univ, Sch Med, Div Oncol, Dept Med, St Louis, MO USA
[6] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[7] Wugen, St Louis, MO USA
[8] City Of Hope, HLA Lab, Duarte, CA USA
来源：
REVISTA CHILENA DE LITERATURA | 2023年 / 108期
关键词：
1ST-IN-HUMAN;
D O I：
10.3324/haematol.2023.283566
中图分类号：
I3/7 [各国文学];
学科分类号：
摘要：
引用
收藏
页码：3511 / 3516
页数：6
相关论文
共 50 条
  • [1] Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy
    Zhang, Xian
    Yang, Junfang
    Li, Jingjing
    Qiu, Liyuan
    Zhang, Jianping
    Lu, Yue
    Zhao, Yan-li
    Jin, David
    Li, Jianqiang
    Lu, Peihua
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : 1898 - 1908
  • [2] Autologous CD7-targeted CAR T-cell therapy for refractory or relapsed T-cell acute lymphoblastic leukemia/lymphoma.
    Zhao, Liping
    Pan, Jing
    Tang, Kaiting
    Tan, Yue
    Deng, Biping
    Ling, Zhuojun
    Song, Weiliang
    Chang, Alex H.
    Feng, Xiaoming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] A Novel Universal CD7-Targeted CAR-T Cell Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma
    Zhang, Xian
    Zhou, Yali
    Yang, Junfang
    Li, Jingjing
    Qiu, Liyuan
    Ge, Wengang
    Pei, Bo
    Chen, Jie
    Han, Lu
    Ren, Jiangtao
    Lu, Peihua
    BLOOD, 2022, 140 : 4566 - 4567
  • [4] Analysis of 60 Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma Treated with CD7-targeted Chimeric Antigen Receptor-T Cell Therapy (vol 98, pg 1898, 2023)
    Zhang, X.
    Yang, J.
    Li, J.
    Qiu, L.
    Zhang, J.
    Lu, Y.
    Zhao, Y. L.
    Jin, D.
    Li, J.
    Lu, P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (06) : 1209 - 1209
  • [5] Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
    Oh, Bernice L. Z.
    Vinanica, Natasha
    Wong, Desmond M. H.
    Campana, Dario
    HAEMATOLOGICA, 2024, 109 (06) : 1677 - 1688
  • [6] CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
    Maude, Shannon L.
    Teachey, David T.
    Porter, David L.
    Grupp, Stephan A.
    BLOOD, 2015, 125 (26) : 4017 - 4023
  • [7] Chimeric antigen receptor T-cell therapy in acute myeloid leukemia
    Koedam, Jan
    Wermke, Martin
    Ehninger, Armin
    Cartellieri, Marc
    Ehninger, Gerhard
    CURRENT OPINION IN HEMATOLOGY, 2022, 29 (02) : 74 - 83
  • [8] Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial
    Xian Zhang
    Junfang Yang
    Jingjing Li
    Liyuan Qiu
    Liu Hongxing, Sr.
    Min Xiong
    Jianqiang Li
    Peihua Lu
    BLOOD, 2023, 142
  • [9] Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
    Ceolin, Valeria
    Brivio, Erica
    van Tinteren, Harm
    Rheingold, Susan R.
    Leahy, Allison
    Vormoor, Britta
    O'Brien, Maureen M.
    Rubinstein, Jeremy D.
    Kalwak, Krzysztof
    De Moerloose, Barbara
    Jacoby, Elad
    Bader, Peter
    Lopez-Duarte, Monica
    Goemans, Bianca F.
    Locatelli, Franco
    Hoogerbrugge, Peter
    Calkoen, Friso G.
    Zwaan, Christian Michel
    LEUKEMIA, 2023, 37 (01) : 53 - 60
  • [10] Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
    Valeria Ceolin
    Erica Brivio
    Harm van Tinteren
    Susan R. Rheingold
    Allison Leahy
    Britta Vormoor
    Maureen M. O’Brien
    Jeremy D. Rubinstein
    Krzysztof Kalwak
    Barbara De Moerloose
    Elad Jacoby
    Peter Bader
    Mónica López-Duarte
    Bianca F. Goemans
    Franco Locatelli
    Peter Hoogerbrugge
    Friso G. Calkoen
    Christian Michel Zwaan
    Leukemia, 2023, 37 : 53 - 60
12345